Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
L3Harris
LHX
$55.9B
| $1.09B | 0.61% |
6,406,292
-692,385
| -10% | -$130M |
|
27
CoStar Group
CSGP
$11.3B
| $1.09B | 0.61% |
15,286,270
+1,011,480
| +7% | +$65.4M |
|
28
Abbott
ABT
$180B
| $1.07B | 0.6% |
11,720,454
+194,150
| +2% | +$17.5M |
|
29
Accenture
ACN
$89.9B
| $1.06B | 0.6% |
4,956,430
+1,011,351
| +26% | +$191M |
|
30
SS&C Technologies
SSNC
$17.8B
| $1.05B | 0.59% |
18,616,257
-335,529
| -2% | -$18.3M |
|
31
American Tower
AMT
$77.7B
| $1.04B | 0.58% |
4,015,816
-62,768
| -2% | -$15.5M |
|
|
32
T-Mobile US
TMUS
$193B
| $1.01B | 0.57% |
9,728,461
+5,529,047
| +132% | +$530M |
|
33
Fidelity National Information Services
FIS
$21.5B
| $997M | 0.56% |
7,437,618
-322,547
| -4% | -$42.4M |
|
34
Blackstone
BX
$104B
| $980M | 0.55% |
17,301,154
+419,358
| +2% | +$22.1M |
|
35
Thermo Fisher Scientific
TMO
$211B
| $965M | 0.54% |
2,664,549
+138,112
| +5% | +$46.3M |
|
36
Danaher
DHR
$135B
| $930M | 0.52% |
5,930,402
+86,448
| +1% | +$12.4M |
|
37
Eli Lilly
LLY
$1.07T
| $914M | 0.51% |
5,564,295
+786,253
| +16% | +$121M |
|
38
Progressive
PGR
$124B
| $901M | 0.51% |
11,244,244
+799,843
| +8% | +$62.4M |
|
39
Aon
AON
$77.3B
| $898M | 0.5% |
4,663,619
+126,657
| +3% | +$23.6M |
|
40
Nice
NICE
$5.29B
| $887M | 0.5% |
4,689,487
-444,390
| -9% | -$77.8M |
|
41
Broadridge
BR
$17.2B
| $836M | 0.47% |
6,623,688
+118,496
| +2% | +$13.7M |
|
42
Neurocrine Biosciences
NBIX
$17.7B
| $792M | 0.44% |
6,494,191
-1,135,008
| -15% | -$125M |
|
43
Humana
HUM
$46.7B
| $769M | 0.43% |
1,982,370
-108,906
| -5% | -$40.7M |
|
44
Intel
INTC
$466B
| $756M | 0.42% |
12,638,116
-335,134
| -3% | -$20M |
|
45
Alibaba
BABA
$269B
| $718M | 0.4% |
3,327,529
-150,442
| -4% | -$31.3M |
|
46
Walt Disney
DIS
$165B
| $717M | 0.4% |
6,434,121
-293,520
| -4% | -$32.4M |
|
47
Elanco Animal Health
ELAN
$12.4B
| $717M | 0.4% |
33,432,143
+2,643,285
| +9% | +$58.4M |
|
|
TMX
48
DELISTED
Terminix Global Holdings, Inc.
TMX
| $716M | 0.4% |
20,064,190
+749,542
| +4% | +$23.1M |
|
|
AVLR
49
DELISTED
Avalara, Inc.
AVLR
| $708M | 0.4% |
5,320,702
-1,073,209
| -17% | -$105M |
|
50
KLA
KLAC
$275B
| $699M | 0.39% |
35,917,650
-2,443,840
| -6% | -$41.8M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.